Market Overview

Zynerba Pharmaceuticals shares are trading higher after the company received a new US patent for treatment of Autism spectrum disorder with cannabidiol.

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: WIIM Markets

 

Related Articles (ZYNE)

Lightning Fast
Market News Service
$199 Free 14 Day Trial

5 Tips To Spring Clean Your Finances

'We're Trying To Be Smart About It': New Canopy Growth CFO Says Cannabis Company Eyeing Financing Options